By Topic

Positron Emission Tomography-Guided Biopsy With a Dedicated Breast Scanner: Initial Evaluation

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)
Raymond R. Raylman ; Dept. of Radiol., West Virginia Univ., Morgantown, WV

Efforts to create dedicated nuclear medicine breast imaging scanners are maturing as they approach more routine clinical use. These systems promise to improve the detection of small lesions, especially those in breasts that are not definitively imaged with standard methods. Since these techniques lack sufficient specificity for accurate diagnoses of cancer, a method for guiding biopsies with these new devices must be developed. In this investigation, a technique that capitalizes upon the three-dimensional, multi-angle positron emission tomography (PET) breast images created by our new positron emission mammography/tomography imaging and biopsy device (PEM-PET) to guide breast biopsies was tested. Specifically, the accuracy and precision of the needle positioning system was measured for each of the three axes of motion. In addition, a biopsy of a simulated breast lesion was performed under realistic imaging conditions. The results from the positioning tests revealed that the system had very good accuracy and precision in all three axes. The maximum positioning error was plusmn 0.27 mm, sufficient to obtain samples from most lesions detected with PEM-PET. In addition, the simulated biopsy was performed successfully on a single attempt in obtaining a sample from a 5-mm-diameter target sphere. This successful test moves the project closer to the next phase of development, initiation of limited human testing.

Published in:

IEEE Transactions on Nuclear Science  (Volume:56 ,  Issue: 3 )